Novabay Pharmaceuticals
$1.95
65
+$0.36+22.64% Today
Statistics
Day High
1.98
Day Low
1.57
52W High
99.75
52W Low
1.11
Volume
616,008
Avg. Volume
543,667
Mkt Cap
245.72M
P/E Ratio
0.5
Dividend Yield
503.14%
Dividend
9.81
Upcoming
Dividends
503.14%Dividend Yield
Sep 25
$4
Sep 25
$4
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
Earnings
7MayExpected
Expected EPS
-1
Actual EPS
N/A
Financials
-88.01%Profit Margin
Unprofitable19.56MRevenue
-17.22MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow NBY. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Ocular Therapeutix
OCUL
Mkt Cap2.47B
National Vision
EYE
Mkt Cap2.09B
Alcon
ALC
Mkt Cap36.88B
Johnson & Johnson
JNJ
Mkt Cap455.04B
Pfizer
PFE
Mkt Cap140.15B
Novartis
NVS
Mkt Cap237.61B
Bausch Health Companies
BHC
Mkt Cap2.62B
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Abbvie
ABBV
Mkt Cap385.18B
About
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
Show more...
CEO
Mr. Tommy Law
Employees
13
Country
US
ISIN
US66987P5089
Listings
0 Comments
Share your thoughts
FAQ
What is Novabay Pharmaceuticals stock price today?▼
The current price of NBY is $1.95 USD — it has increased by +22.64% in the past 24 hours. Watch Novabay Pharmaceuticals stock price performance more closely on the chart.
What is Novabay Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Novabay Pharmaceuticals stocks are traded under the ticker NBY.
Is Novabay Pharmaceuticals stock price growing?▼
NBY stock has risen by +27.45% compared to the previous week, the month change is a +36.36% rise, over the last year Novabay Pharmaceuticals has showed a -31.82% decrease.
What is Novabay Pharmaceuticals market cap?▼
Today Novabay Pharmaceuticals has the market capitalization of 245.72M
When is the next Novabay Pharmaceuticals earnings date?▼
Novabay Pharmaceuticals is going to release the next earnings report on May 07, 2026.
What were Novabay Pharmaceuticals earnings last quarter?▼
NBY earnings for the last quarter are -1.15 USD per share, whereas the estimation was -1.05 USD resulting in a -9.52% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Novabay Pharmaceuticals revenue for the last year?▼
Novabay Pharmaceuticals revenue for the last year amounts to 19.56M USD.
What is Novabay Pharmaceuticals net income for the last year?▼
NBY net income for the last year is -17.22M USD.
Does Novabay Pharmaceuticals pay dividends?▼
Yes, NBY dividends are paid en. The last dividend per share was 4 USD. As of today, Dividend Yield (FWD)% is 503.14%.
How many employees does Novabay Pharmaceuticals have?▼
As of April 02, 2026, the company has 13 employees.
In which sector is Novabay Pharmaceuticals located?▼
Novabay Pharmaceuticals operates in the Health Care sector.
When did Novabay Pharmaceuticals complete a stock split?▼
The last stock split for Novabay Pharmaceuticals was on February 23, 2026 with a ratio of 1:5.
Where is Novabay Pharmaceuticals headquartered?▼
Novabay Pharmaceuticals is headquartered in Emeryville, US.